Biofrontera

BFRA NASDAQ
14.38
-0.10
-0.67%
交易中 09:30 08/19 EDT
开盘
14.38
昨收
15.56
最高
14.38
最低
14.38
成交量
4
成交均量(3M)
3,209
52周最高
18.32
52周最低
11.04
换手率
0.00%
市值
6.44亿
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Biofrontera BFRA股票价格,Biofrontera股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Biofrontera AG is a Germany-based biopharmaceutical company. The Company develops drugs and medicinal cosmetics for the treatment of skin diseases and regenerative care of damaged skin. Its portfolio includes: Ameluz, for photodynamic therapy (PDT) of actinic keratoses, and under development for other types of skin cancer and warts; PDT lamp BF-RhodoLED, used after the Ameluz treatment to eliminate infected cells; and Belixos, a dermatological cream with herbal ingredients for the care of itching, inflamed and flaky skin and conditions such as insect bites, burns, neurodermatitis and psoriasis. The Company is also engaged in clinical development of two drug candidates: BF-derm1, a tablet with inhibitor blocking the synthesis of histamine in cells, a cause of allergic reactions; and BF1, a selective serotonin receptor to prevent migraines. The Company operates five wholly owned subsidiaries, notably Biofrontera Inc in the United States. Its main shareholder is MM Familien KG.
展开 >

最近浏览

名称
价格
涨跌幅